These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
66 related articles for article (PubMed ID: 24974699)
1. This time it's personal. Gravitz L Sci Am; 2014 Jul; 311(1):S6-8. PubMed ID: 24974699 [No Abstract] [Full Text] [Related]
2. KIT mutations in a series of melanomas and their impact on treatment with imatinib. Botella-Estrada R; Soriano V; Rubio L; Nagore E Actas Dermosifiliogr; 2012 Nov; 103(9):838-40. PubMed ID: 22795573 [No Abstract] [Full Text] [Related]
3. Counterpoint: Data first. Golub T Nature; 2010 Apr; 464(7289):679. PubMed ID: 20360719 [No Abstract] [Full Text] [Related]
4. Management of gastrointestinal stromal tumor: the imatinib era and beyond. Parikh PM; Gupta S Indian J Cancer; 2013; 50(1):31-40. PubMed ID: 23713042 [TBL] [Abstract][Full Text] [Related]
6. In pursuit of patents. Huilgol N J Cancer Res Ther; 2013; 9(2):177-8. PubMed ID: 23771353 [No Abstract] [Full Text] [Related]
7. Imatinib: the promise of a "magic bullet" for cancer fulfilled. Henderson CA J Med Assoc Ga; 2003; 92(1):12-4, 22. PubMed ID: 12743899 [No Abstract] [Full Text] [Related]
16. Imatinib-induced amelioration of neurologic deficits in a rare case of simultaneous association of missed multiple sclerosis and chronic myeloblastic leukemia. Siroos B; Harirchian MH; Abolfazli R Mult Scler; 2013 Aug; 19(9):1238-9. PubMed ID: 23339135 [No Abstract] [Full Text] [Related]
17. Imatinib results in better outcomes than HLA-identical sibling transplants in young persons with newly diagnosed chronic-phase chronic myelogenous leukemia. Jiang Q; Xu LP; Liu DH; Liu KY; Gale RP; Zhang MJ; Jiang B; Zhang XH; Wang Y; Chen SS; Zhao XY; Chen H; Jiang H; Chen YH; Han W; Qin YZ; Liu YR; Lai YY; Lv M; Huang XJ Leukemia; 2013 Dec; 27(12):2410-3. PubMed ID: 23698276 [No Abstract] [Full Text] [Related]
18. Tyrosine kinase inhibitors: views of selectivity, sensitivity, and clinical performance. Levitzki A Annu Rev Pharmacol Toxicol; 2013; 53():161-85. PubMed ID: 23043437 [TBL] [Abstract][Full Text] [Related]
19. Imatinib and beyond in gastrointestinal stromal tumors: A radiologist's perspective. Tirumani SH; Jagannathan JP; Krajewski KM; Shinagare AB; Jacene H; Ramaiya NH AJR Am J Roentgenol; 2013 Oct; 201(4):801-10. PubMed ID: 24059369 [TBL] [Abstract][Full Text] [Related]
20. [c-kit: an irresistible ascension from diagnostic marker to therapeutic]. Scoazec JY Ann Pathol; 2002 Jun; 22(3):173-5. PubMed ID: 12410099 [No Abstract] [Full Text] [Related] [Next] [New Search]